Back to Company Profile

Alpha Profiles · Company Profile

RESMED INC

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/resmed-inc

Entity: Public listing published
Primary listing: NYSE: RMD
Verification: Partially verified
Last reviewed: 2026-10-16T13:54:19.075066+00:00

Overview

Alpha's canonical identity and public leadership record for RESMED INC.

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

4 public records

Brett Sandercock

Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0000943819-25-000079Oct 2, 2025

Chief Product Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0000943819-25-000079Oct 2, 2025

Michael Farrell

Chairman and Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0000943819-25-000079Oct 2, 2025

Global General Counsel and Secretary

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0000943819-25-000079Oct 2, 2025

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Oct 16, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.

Board roles

11 public records

Michael Farrell

Chair

Board chairIndependence not stated

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: ResMed Inc. director board sourceOct 2, 2025

Director

Independence not statedAuditCompliance, Privacy and QualityNominating and Governance · Chair

State: confirmed
Effective: From Oct 2, 2025
Confidence: 92%
Evidence: RMD DEF 14A director slateOct 2, 2025

Christopher DelOrefice

Director

Independence not statedAudit · Chair

State: confirmed
Effective: From Oct 2, 2025
Confidence: 92%
Evidence: RMD DEF 14A director slateOct 2, 2025

Director

Independence not statedCompensation and Leadership DevelopmentNominating and Governance

State: confirmed
Effective: From Oct 2, 2025
Confidence: 92%
Evidence: RMD DEF 14A director slateOct 2, 2025

Director

Independence not statedAuditCompensation and Leadership DevelopmentCompliance, Privacy and Quality

State: confirmed
Effective: From Oct 2, 2025
Confidence: 92%
Evidence: RMD DEF 14A director slateOct 2, 2025

Director

Independence not statedAuditCompensation and Leadership DevelopmentNominating and Governance

State: confirmed
Effective: From Oct 2, 2025
Confidence: 92%
Evidence: RMD DEF 14A director slateOct 2, 2025

Director

Independence not statedAuditCompliance, Privacy and Quality

State: confirmed
Effective: From Oct 2, 2025
Confidence: 92%
Evidence: RMD DEF 14A director slateOct 2, 2025

Director

Independence not statedCompensation and Leadership Development · ChairCompliance, Privacy and QualityNominating and Governance

State: confirmed
Effective: From Oct 2, 2025
Confidence: 92%
Evidence: RMD DEF 14A director slateOct 2, 2025

Nicole Mowad-Nassar

Director

Independence not statedCompliance, Privacy and Quality

State: confirmed
Effective: From Oct 2, 2025
Confidence: 92%
Evidence: RMD DEF 14A director slateOct 2, 2025

Director

Independence not stated

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: ResMed Inc. director board sourceOct 2, 2025

Lead Independent Director

Independence not statedAudit

State: confirmed
Effective: From Oct 2, 2025
Confidence: 92%
Evidence: RMD DEF 14A director slateOct 2, 2025

Committees

4 public records

Membership and chair roles are projected from current board seats. A chair is shown only when a stored chair flag says so.

Audit

Chair: Christopher DelOrefice
Members: Christopher DelOrefice (Chair); Carol Burt; Harjit Gill; Jerry D. Witte; John Hernandez; Ross Taylor

Compensation and Leadership Development

Chair: Karen Drexler
Members: Karen Drexler (Chair); Desney Tan; Harjit Gill; Jerry D. Witte

Compliance, Privacy and Quality

Chair: Not stated
Members: Carol Burt; Harjit Gill; John Hernandez; Karen Drexler; Nicole Mowad-Nassar

Nominating and Governance

Chair: Carol Burt
Members: Carol Burt (Chair); Desney Tan; Jerry D. Witte; Karen Drexler

Source record

Alpha canonical company public projection

Supports Company identity, Published leadership, Entity status boundary

Reviewed 2026-10-16T13:54:19.075066+00:00

RESMED INC Form 10-K (filed 2026-08-13)

Supports Official website

Reviewed 2026-08-29T22:29:40Z